834
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Safety of Alprazolam Use in Pregnancy in Western Australia: A Retrospective Cohort Study Using Linked Health Data

, BSc MBioStat, PhDORCID Icon, , BSc, PhDORCID Icon & , BSc, PhDORCID Icon
Received 28 Mar 2023, Accepted 29 Jun 2023, Published online: 28 Jul 2023

References

  • Abdel-Latif, M. E., B. Bajuk, K. Lui, J. Oei, and N. S. W. on A. C. T. Neonatal Intensive Care Units’ Study Group the. 2007. Short-term outcomes of infants of substance-using mothers admitted to neonatal intensive care units in New South Wales and the Australian Capital Territory. Journal of Paediatrics and Child Health 43 (3):127–33. doi:10.1111/j.1440-1754.2007.01031.x.
  • Altvorst, V., E. W. A. Marlies, H. Eliza, Y. Chan, S. Rennae, L. C. Taylor, J. Kenny, E. Myers, A. Gustaaf, R. A. Dekker, et al. 2012. Antepartum haemorrhage of unknown origin and maternal cigarette smoking beyond the first trimester. The Australian & New Zealand Journal of Obstetrics & Gynaecology 52 (2): 161–66. doi:10.1111/j.1479-828X.2011.01398.x.
  • ATC and DDD Index. 2022. “ATC/DDD Index 2022.” WHO Collaborating Centre for Drug Statistic Methodology, accessed 25 02 2022. https://www.whocc.no/atc_ddd_index/.
  • Bais, B., N. M. Molenaar, H. H. Bijma, W. J. G. Hoogendijk, C. L. Mulder, A. I. Luik, P. Mijke, L.-V. den Berg, and A. M. Kamperman. 2020. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis. Journal of Affective Disorders 269:18–27. doi:10.1016/j.jad.2020.03.014.
  • Ban, L., J. West, J. E. Gibson, L. Fiaschi, R. Sokal, P. Doyle, R. Hubbard, L. Smeeth, L. J. Tata, and J. Homberg. 2014. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: A United Kingdom population-based cohort study. PLOS ONE 9 (6):e100996. doi:10.1371/journal.pone.0100996.
  • Bellantuono, C., S. Tofani, G. Di Sciascio, and G. Santone. 2013. Benzodiazepine exposure in pregnancy and risk of major malformations: A critical overview. General Hospital Psychiatry 35 (1):3–8. doi:10.1016/j.genhosppsych.2012.09.003.
  • Blair, E. M., Y. Liu, N. H. de Klerk, and D. M. Lawrence. 2005. Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: An analysis of a total population perinatal database. BMC Pediatrics 5 (1):13. doi:10.1186/1471-2431-5-13.
  • Cunningham, C. M., G. E. Hanley, and S. Morgan. 2010. Patterns in the use of benzodiazepines in British Columbia: Examining the impact of increasing research and guideline cautions against long-term use. Health Policy 97 (2):122–29. doi:10.1016/j.healthpol.2010.03.008.
  • Freeman, M. P., L. Góez-Mogollón, K. A. McInerney, A. C. Davies, T. R. Church, A. Z. Sosinsky, O. B. Noe, A. C. Viguera, and L. S. Cohen. 2018. Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. General Hospital Psychiatry 53:73–79. doi:10.1016/j.genhosppsych.2018.05.010.
  • Grigoriadis, S., L. Graves, M. Peer, L. Mamisashvili, C. L. Dennis, S. N. Vigod, M. Steiner, C. Brown, A. Cheung, H. Dawson, et al. 2019. Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis. The Journal ofClinical Psychiatry 80(4). doi:10.4088/JCP.18r12412.
  • Huitfeldt, A., L. M. Sundbakk, S. Skurtveit, M. Handal, and H. Nordeng. 2020. Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. JAMA Network Open 3 (6):e205860–e205860. doi:10.1001/jamanetworkopen.2020.5860.
  • Hulse, G. K., E. Milne, D. R. English, and C. D. J. Holman. 1998. Assessing the relationship between maternal opiate use and antepartum haemorrhage. Addiction 93 (10):1553–58. doi:10.1046/j.1360-0443.1998.9310155312.x.
  • Källén, B. 2019. Maternal use of sedatives or hypnotics and infant congenital malformations. In Maternal drug use and infant congenital malformations, 289–98. Cham: Springer International Publishing.
  • Kennare, R., A. Heard, and A. Chan. 2005. Substance use during pregnancy: Risk factors and obstetric and perinatal outcomes in South Australia. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45 (3):220–25. doi:10.1111/j.1479-828X.2005.00379.x.
  • Laegreid, L., G. Hagberg, and A. Lundberg. 1992. The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 23 (1):18–23. doi:10.1055/s-2008-1071305[doi].
  • Lee, H., J.-W. Koh, Y.-A. Kim, K.-C. Chun, J. Yeol Han, J. Hee Hwang, J.-S. Choi, S. Hong Joo, and H.-Y. Kwon. 2022. Pregnancy and neonatal outcomes after exposure to alprazolam in pregnancy. Frontiers in Pharmacology 13:854562–854562. doi:10.3389/fphar.2022.854562.
  • MIMS. 2023. MIMS Online. Sydney, Australia: MIMS Australia Pty Ltd.
  • Olfson, M., M. King, and M. Schoenbaum. 2015. Benzodiazepine Use in the United States. JAMA Psychiatry 72 (2):136–42. doi:10.1001/jamapsychiatry.2014.1763.
  • Rajiv, K. R., and A. Radhakrishnan. 2019. Status epilepticus in pregnancy – Can we frame a uniform treatment protocol? Epilepsy & Behavior 101:106376. doi:10.1016/j.yebeh.2019.06.020.
  • Rementería, J. L., and K. Bhatt. 1977. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. The Journal of Pediatrics 90 (1):123–26. doi:10.1016/S0022-3476(77)80785-3.
  • Review of PBS utilisation. 2015. “Alprazolam: Review of PBS utilisation following rescheduling to Schedule 8.” Drug Utilisation Sub-Committee (DUSC), accessed 24 06 2022. https://www.pbs.gov.au/pbs/industry/listing/participants/public-release-docs/2015-10/alprazolam-dusc-prd-2015-10-abstract.
  • Riska, B. S., S. Skurtveit, K. Furu, A. Engeland, and M. Handal. 2014. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: A population-based cohort study. European Journal of Clinical Pharmacology 70 (11):1367–74. doi:10.1007/s00228-014-1744-4.
  • Scheduling handbook. 2019. Scheduling handbook: Guidance for amending the poisons standard. Australian Government Department of Health: Canberra.edited by Therapeutic Goods Administration.
  • Sheehy, O., J.-P. Zhao, and A. Bérard. 2019. Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry 76 (9):948–57. doi:10.1001/jamapsychiatry.2019.0963.
  • Tasci, Y., B. Demir, S. Dilbaz, and A. Haberal. 2009. Use of diazepam for hyperemesis gravidarum. The Journal of Maternal-Fetal & Neonatal Medicine 22 (4):353–56. doi:10.1080/14767050802464528.
  • Tinker, S. C., J. Reefhuis, R. H. Bitsko, S. M. Gilboa, A. A. Mitchell, E. L. Tran, M. M. Werler, C. S. Broussard, and Study the National Birth Defects Prevention. 2019. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, national birth defects prevention study, 1997–2011. Birth Defects Research 111 (10):613–20. doi:10.1002/bdr2.1497.
  • Wikner, B. N., C. O. Stiller, U. Bergman, C. Asker, and B. Kallen. 2007. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: Neonatal outcome and congenital malformations. Pharmacoepidemiology and Drug Safety 16 (11):1203–10. doi:10.1002/pds.1457.